The Innovation Space — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
NKA Bionkabio.cominMar 2023
NKA Bio develops antibody-based medicines for critically ill and trauma patients to extend survival time during medical emergencies.
BiotechHealthtechMedical DevicesBaltimore, US
Lewis C. Hibbs(Executive Officer, Director)Les E. Johnson(Executive Officer, Director)Susan G. Hibbs(Executive Officer, Director)
Co-investorsTechstars
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.